Tirzepatide is a leading dual-agonist in G13’s GLP research category.
Classification
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it targets two incretin receptors, placing it between single agonists like Semaglutide and triple agonists like Retatrutide.
In research
Studied in metabolic-pathway research where combined dual-receptor activity is the variable of interest. Mechanism for research reference only — not outcomes.
Specifications & verification
10mg lyophilized vial, ≥99% purity standard; store at -20°C. Independent, lot-matched HPLC COA (current lot CS-ze101018). New to COAs? See How to Read a Peptide COA.
Tirzepatide is a research reference material for laboratory research use only. Not for human consumption.